GO:0061951 establishment of protein localization to plasma membrane: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061951 describes the directed movement of a protein to a specific location in the plasma membrane, a process essential for signal transduction, cell polarity, and host-pathogen interactions.
• Protein localization to the plasma membrane often depends on lipid modifications such as palmitoylation, which targets proteins like calcineurin to the phosphatidylinositol 4-kinase complex.
• Membrane lipid composition, including phosphatidic acid and phosphatidylserine, can dictate selective protein recruitment to the plasma membrane.
• Dysregulation of plasma membrane protein localization is linked to heart failure, cancer, and neurological disorders.
• Advanced imaging and biochemical methods, such as HaloTag-based quantification and co-localization assays, are critical for studying this process.
• CRISPR-based models (knockout, knock-in, point mutation, overexpression) enable causal interrogation of genes involved in plasma membrane targeting.
Description
The establishment of protein localization to the plasma membrane (GO:0061951) is a fundamental biological process that ensures proteins are delivered to and retained at the cell surface. This process is critical for diverse cellular functions, including signal reception, cell adhesion, and communication with the extracellular environment. Defects in this targeting mechanism can lead to a wide range of pathologies, from cardiovascular disease to cancer. Understanding how proteins are directed to the plasma membrane is therefore a central question in cell biology and medicine. Research has identified multiple mechanisms that mediate this localization, including lipid modifications such as palmitoylation and interactions with specific membrane lipids. For example, palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membrane, illustrating how post-translational modifications can control protein destination. Similarly, bacterial effectors can anchor to the plasma membrane via selective phosphatidic acid binding to modulate host cell signaling, highlighting the importance of this process in infection. This article synthesizes current knowledge on the mechanisms, key genes, and research methods associated with GO:0061951, providing a resource for researchers studying protein trafficking and membrane dynamics.
establishment of protein localization to plasma membrane At A Glance
| GO ID | GO:0061951 |
|---|---|
| GO term | establishment of protein localization to plasma membrane |
| Ontology | biological_process |
| Synonym | None |
| Major function | Directed movement of proteins to specific locations in the plasma membrane |
| Related processes | Protein targeting, membrane trafficking, signal transduction |
| Key mechanisms | Palmitoylation, lipid binding, vesicular transport |
| Disease relevance | Heart failure, cancer, neurological disorders |
What Is GO:0061951?
GO:0061951, establishment of protein localization to plasma membrane, is defined as the directed movement of a protein to a specific location in a plasma membrane. This encompasses the processes that ensure a protein is transported to and positioned at the plasma membrane, which may involve vesicular trafficking, diffusion and retention, or direct membrane insertion. The term focuses on the establishment of localization, distinguishing it from maintenance or regulation of localization.
Why Is establishment of protein localization to plasma membrane Important in Cell Biology?
The establishment of protein localization to the plasma membrane is vital for cellular function because the plasma membrane serves as the interface between the cell and its environment. Proteins localized to the plasma membrane are involved in sensing external signals, transporting ions and nutrients, and mediating cell-cell interactions. Disruption of this process can impair these functions, leading to diseases such as heart failure, where GPLD1 attenuates heart failure via dual-membrane localization to inhibit uPAR. Therefore, understanding the mechanisms that govern protein targeting to the plasma membrane is essential for both basic biology and the development of therapeutic strategies.
• Enables signal transduction by positioning receptors and channels at the cell surface.
• Critical for cell polarity and polarized growth in organisms from plants to humans.
• Plays a key role in host-pathogen interactions, as bacterial effectors can hijack plasma membrane localization.
• Dysregulation is linked to cardiovascular diseases such as heart failure.
• Alterations in plasma membrane protein localization contribute to cancer progression and metastasis.
• Essential for neuronal function, where mislocalization of channels can cause neurological disorders.
• Involved in immune responses, including interleukin-1α and annexin A2 co-localization at the plasma membrane under oxidative stress.
• Targeting this process offers potential for therapeutic intervention in multiple diseases.
• Provides a model for studying fundamental cell biology, including membrane trafficking and lipid-protein interactions.
• Advances in imaging and CRISPR technologies are accelerating research in this field.
What Happens During establishment of protein localization to plasma membrane?
Protein Synthesis and Initial Targeting
In simple terms: Proteins are made and then tagged for delivery to the cell membrane.
Proteins destined for the plasma membrane are synthesized in the cytoplasm or at the endoplasmic reticulum (ER). They often contain signal sequences or motifs that direct them to the secretory pathway. For example, the calcineurin phosphatase is targeted to the plasma membrane via palmitoylation, a lipid modification that occurs after synthesis. This step is crucial for determining the ultimate destination of the protein.
Vesicular Trafficking and Transport
In simple terms: Proteins are packaged into vesicles and transported to the membrane.
After synthesis and modification, proteins are packaged into vesicles that bud from the ER and Golgi apparatus. These vesicles are then transported along the cytoskeleton to the plasma membrane. This process involves a complex machinery of coat proteins, Rab GTPases, and SNARE proteins. The directed movement ensures that proteins reach the correct location, as described in the definition of GO:0061951. Lipid flippases, which regulate membrane lipid asymmetry, are important for polarized growth and likely influence vesicle trafficking to the plasma membrane.
Membrane Anchoring and Retention
In simple terms: Once at the membrane, proteins are anchored or retained there.
Upon reaching the plasma membrane, proteins must be anchored or retained to establish their localization. This can occur through transmembrane domains, lipid modifications (e.g., palmitoylation, myristoylation), or interactions with specific lipids. For instance, bacterial effectors can anchor to the plasma membrane via selective phosphatidic acid binding. Similarly, the Arabidopsis acyl-CoA binding protein ACBP2 localizes to the membrane, likely through lipid interactions. Palmitoylation targets calcineurin to the phosphatidylinositol 4-kinase complex at the plasma membrane, demonstrating a specific anchoring mechanism.
Regulation and Dynamics
In simple terms: The process is controlled and can change in response to signals.
The establishment of protein localization to the plasma membrane is dynamically regulated. For example, oxidative stress can induce co-localization of interleukin-1α and annexin A2 at the plasma membrane. Plasma membrane estrogen receptors are also dynamically localized, influencing cellular responses. This regulation ensures that proteins are present at the right place and time. The process can be studied using advanced techniques such as HaloTag-based quantification of subcellular localization.
Key Genes Involved in GO:0061951 establishment of protein localization to plasma membrane
The following genes and proteins are key players in the establishment of protein localization to the plasma membrane, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPLD1 | Dual-membrane localization to inhibit uPAR, attenuating heart failure | Cardiovascular disease model |
| TRPV3 | Ion channel; subcellular localization quantified via HaloTag | Neurological and skin disorders |
| Calcineurin (PPP3CA) | Palmitoylation targets it to phosphatidylinositol 4-kinase complex at plasma membrane | Signal transduction studies |
| P4KA | Phosphatidylinositol 4-kinase; interacts with calcineurin at plasma membrane | Membrane lipid signaling |
| Lipid flippases (e.g., P4-ATPases) | Regulate membrane lipid asymmetry for polarized growth | Cell polarity and development |
| IL1A | Co-localizes with Annexin A2 at plasma membrane under oxidative stress | Inflammation and stress responses |
| ANXA2 | Co-localizes with IL1A at plasma membrane | Membrane repair and inflammation |
| Bacterial effector (e.g., from pathogens) | Anchors at plasma membrane via phosphatidic acid binding | Host-pathogen interactions |
| ESR1 | Plasma membrane estrogen receptor | Endocrinology and cancer |
| ACBP2 | Membrane localization in Arabidopsis | Plant lipid metabolism |
| uPAR (PLAUR) | Target of GPLD1; involved in heart failure | Cardiovascular disease |
| HaloTag-fused proteins | Tool for quantifying subcellular localization | Imaging and trafficking studies |
| Ras GTPases | Palmitoylation-dependent plasma membrane localization | Cancer signaling |
| SNARE proteins | Mediate vesicle fusion at plasma membrane | Neurotransmission and secretion |
| Rab GTPases | Regulate vesicular trafficking to plasma membrane | Membrane transport |
| Phosphatidic acid | Lipid that recruits effectors to plasma membrane | Host-pathogen interactions |
| Annexin A2 | Calcium-dependent membrane binding protein | Membrane dynamics |
How Is establishment of protein localization to plasma membrane Regulated?
The establishment of protein localization to the plasma membrane is regulated at multiple levels. Post-translational modifications such as palmitoylation can direct proteins to specific membrane domains, as shown for calcineurin. Lipid composition, including the presence of phosphatidic acid, can selectively recruit proteins to the plasma membrane. Oxidative stress can induce co-localization of specific proteins like interleukin-1α and annexin A2. Additionally, the process is influenced by cellular signaling pathways that control vesicular trafficking and membrane dynamics. For example, plasma membrane estrogen receptors are regulated by hormonal signals. These regulatory mechanisms ensure that protein localization is dynamic and responsive to cellular needs.
establishment of protein localization to plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPLD1 | Heart failure | Knockout mouse model, overexpression in cardiomyocytes |
| TRPV3 | Neurological disorders, skin disorders | HaloTag knock-in for localization studies |
| ESR1 | Cancer (breast, endometrial) | Point mutation to alter membrane localization |
| Bacterial effector (e.g., from Pseudomonas) | Infectious disease | Knock-in of effector into host cells |
| IL1A/ANXA2 | Inflammation, oxidative stress | Co-localization assays under stress |
Cardiovascular Disease
GPLD1 attenuates heart failure via dual-membrane localization to inhibit uPAR, highlighting the importance of plasma membrane protein localization in cardiac function. Disruption of this process can contribute to heart failure pathogenesis.
Cancer
Plasma membrane estrogen receptors play roles in cancer cell proliferation and survival. Mislocalization of signaling proteins such as Ras GTPases, which depend on palmitoylation for plasma membrane targeting, can lead to oncogenic signaling.
Neurological Disorders
TRPV3 channels must localize to the plasma membrane for proper function; altered localization can contribute to neurological and skin disorders. Precise targeting of ion channels is essential for neuronal excitability.
Infectious Diseases
Bacterial effectors anchor at the plasma membrane via selective phosphatidic acid binding to modulate host cell signaling, illustrating how pathogens exploit this process. Understanding these mechanisms can inform therapeutic strategies.
From establishment of protein localization to plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X localize to plasma membrane? | Tagged knock-in (e.g., HaloTag, GFP) |
| Is palmitoylation required for membrane targeting? | Point mutation of cysteine residues |
| What is the role of gene X in heart failure? | Knockout mouse, overexpression |
| How does a bacterial effector anchor to plasma membrane? | Knock-in of effector, lipid binding assays |
| Does oxidative stress alter protein localization? | Co-localization imaging under stress |
| Is lipid flippase activity required for polarized growth? | Knockout in model organisms |
How to Study the establishment of protein localization to plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HaloTag imaging | Subcellular localization and quantification | TRPV3 channel localization |
| Co-localization immunofluorescence | Spatial overlap of proteins at plasma membrane | IL1A and ANXA2 under oxidative stress |
| Membrane fractionation + mass spectrometry | Protein composition of plasma membrane | Identifying novel membrane proteins |
| CRISPR knockout | Loss-of-function effects on localization | GPLD1 in heart failure |
| Point mutation | Role of specific residues in localization | Palmitoylation sites in calcineurin |
| Lipid binding assay | Direct interaction with lipids | Bacterial effector binding to phosphatidic acid |
| Live-cell imaging | Dynamic changes in protein localization | Plasma membrane estrogen receptors |
| Proximity ligation assay | In situ protein-protein interactions at membrane | Calcineurin-P4K complex |
Imaging and Localization Quantification
Advanced imaging techniques such as HaloTag-based quantification allow precise measurement of subcellular localization of proteins like TRPV3 channels. Co-localization assays using immunofluorescence can visualize proteins at the plasma membrane under various conditions.
Biochemical Fractionation and Proteomics
Membrane fractionation followed by mass spectrometry can identify proteins localized to the plasma membrane. This approach can reveal changes in localization in response to stimuli or genetic perturbations.
Genetic Manipulation with CRISPR
CRISPR-Cas9 can be used to knock out, knock in, or point-mutate genes involved in plasma membrane localization. For example, knockout of GPLD1 can assess its role in heart failure, while point mutations can test the requirement for palmitoylation sites.
Lipid Interaction Assays
Protein-lipid overlay assays and liposome binding assays can determine whether a protein binds specific lipids like phosphatidic acid, as shown for bacterial effectors. These methods help elucidate the mechanisms of membrane anchoring.
How CRISPR Can Be Used to Study GO:0061951 establishment of protein localization to plasma membrane
Knockout
CRISPR knockout of genes such as GPLD1 can reveal their role in plasma membrane localization and associated diseases like heart failure. Knockout models are essential for loss-of-function studies.
Point Mutation
Introducing point mutations in genes like calcineurin can test the importance of palmitoylation sites for plasma membrane targeting. This approach provides mechanistic insights into localization signals.
Knock-in
Knock-in of tagged versions of proteins, such as HaloTag-TRPV3, allows real-time tracking of localization to the plasma membrane. This is valuable for dynamic studies.
Overexpression
Overexpression of genes like GPLD1 can assess sufficiency in localizing to the plasma membrane and modulating disease phenotypes. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports establishment of protein localization to plasma membrane Research
Researchers studying establishment of protein localization to plasma membrane-related genes often need to determine whether a candidate gene is causally involved in targeting or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from gene knockout to precise point mutations and knock-in of tags.
Contact EDITGENE today to design your custom CRISPR model for establishment of protein localization to plasma membrane research.
Frequently Asked Questions About establishment of protein localization to plasma membrane
What is GO:0061951?
GO:0061951 is the Gene Ontology term for the biological process 'establishment of protein localization to plasma membrane', defined as the directed movement of a protein to a specific location in a plasma membrane.
What genes are involved in establishment of protein localization to plasma membrane?
Key genes include GPLD1, TRPV3, calcineurin (PPP3CA), P4KA, IL1A, ANXA2, ESR1, and ACBP2, among others.
How does palmitoylation affect protein localization to the plasma membrane?
Palmitoylation can target proteins such as calcineurin to the phosphatidylinositol 4-kinase complex at the plasma membrane, serving as a key mechanism for localization.
What diseases are associated with defects in protein localization to the plasma membrane?
Defects are linked to heart failure, cancer, neurological disorders, and infectious diseases.
What methods are used to study protein localization to the plasma membrane?
Methods include HaloTag-based imaging, co-localization immunofluorescence, membrane fractionation, CRISPR knockout, point mutation, and lipid binding assays.
How can CRISPR be used to study plasma membrane protein localization?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to test gene function and localization signals.
What is the role of lipid flippases in plasma membrane localization?
Lipid flippases regulate membrane lipid asymmetry and are important for polarized growth, influencing protein localization.
How do bacterial effectors anchor to the plasma membrane?
Some bacterial effectors anchor via selective phosphatidic acid binding to modulate host cell signaling.
What is the significance of plasma membrane estrogen receptors?
Plasma membrane estrogen receptors mediate rapid signaling and are involved in cancer and endocrinology.
Can oxidative stress affect protein localization to the plasma membrane?
Yes, oxidative stress can induce co-localization of interleukin-1α and annexin A2 at the plasma membrane.
Conclusion
The establishment of protein localization to the plasma membrane (GO:0061951) is a critical biological process that ensures proteins reach their correct destination at the cell surface. This process is mediated by diverse mechanisms including palmitoylation, lipid binding, and vesicular trafficking, and is essential for normal physiology. Dysregulation contributes to major diseases such as heart failure, cancer, and neurological disorders. Advances in CRISPR-based models and imaging technologies are enabling deeper insights into the molecular players and regulatory networks. Continued research in this area promises to uncover new therapeutic targets and strategies.
References
- 1. Yu W et al.. 2025. GPLD1 Attenuates Heart Failure via Dual-Membrane Localization to Inhibit uPAR.. Circ Res 137(5):e124-e143 PMID: 40631685
- 2. Holloway A et al.. 2026. HaloTag-based approach to quantify subcellular localization of TRPV3 channels.. Biophys J 125(7):1667-1685 PMID: 41787805
- 3. Ulengin-Talkish I et al.. 2021. Palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membrane.. Nat Commun 12(1):6064 PMID: 34663815
- 4. López-Marqués RL. 2021. Lipid flippases in polarized growth.. Curr Genet 67(2):255-262 PMID: 33388852
- 5. Novák J et al.. 2020. Co-localization of Interleukin-1α and Annexin A2 at the plasma membrane in response to oxidative stress.. Cytokine 133:155141 PMID: 32615410
- 6. Wang M et al.. 2024. Anchorage of bacterial effector at plasma membrane via selective phosphatidic acid binding to modulate host cell signaling.. PLoS Pathog 20(11):e1012694 PMID: 39531410
- 7. Levin ER. 2009. Plasma membrane estrogen receptors.. Trends Endocrinol Metab 20(10):477-82 PMID: 19783454
- 8. Li HY et al.. 2003. Membrane localization of Arabidopsis acyl-CoA binding protein ACBP2.. Plant Mol Biol 51(4):483-92 PMID: 12650615
